Clinical trial
Concurrent Xeloda and Radiotherapy for Bone Metastases
NCT00192777 · Rambam Health Care Campus, Other · Unknown status
Key facts
| NCT number | NCT00192777 |
|---|---|
| Title | Concurrent Xeloda and Radiotherapy for Bone Metastases |
| Official title | Concurrent Xeloda and Radiotherapy for Bone Metastases |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Solid Tumors, Bone Metastases |
| Intervention type | Drug, Procedure |
| Interventions | Xeloda, External Beam Radiotherapy |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 8, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: